AI assistant
Sending…
HALLIBURTON CO — Director's Dealing 2021
Jan 8, 2021
30269_dirs_2021-01-08_d45fc36b-2fe8-47f5-a5ef-4a7be604fda0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HALLIBURTON CO (HAL)
CIK: 0000045012
Period of Report: 2021-01-07
Reporting Person: Loeffler Lance (EVP & Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-07 | Common Stock | F | 620 | $18.83 | Disposed | 151127 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Buy Common Stock (12/2018) | $31.44 | 2028-12-05 | Common Stock (51100) | 51100 | Direct |
| Option to Buy Common Stock (01/2018) | $49.61 | 2028-01-02 | Common Stock (20416) | 20416 | Direct |
| Option to Buy Common Stock | $55.68 | 2027-01-03 | Common Stock (16678) | 16678 | Direct |
| Option to Buy Common Stock | $34.48 | 2026-01-04 | Common Stock (27912) | 27912 | Direct |
| Option to Buy Common Stock | $39.49 | 2025-01-02 | Common Stock (15594) | 15594 | Direct |
Footnotes
F1: Shares transferred to Halliburton Company for payment for Federal tax withholding obligations on lapse of restrictions on shares issued under the Stock and Incentive Plan. Said Plan permits Reporting Person to satisfy withholding tax obligation by transferring unrestricted shares to the Issuer.
F2: The shares vested on January 4, 2021. The closing price of Halliburton Company's Common Stock on the New York Stock Exchange on January 4, 2021 was $18.83.
More from HALLIBURTON CO
Registration Form
2026
May 20
Regulatory Filings
2026
May 20
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 24
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 30
Regulatory Filings
2026
Mar 27